-
Barrier to a Cure: Limited Eligibility for Alzheimer’s Patients
Reading Time: 4 minutes. In a surprising twist, many Alzheimer’s patients are unable to access promising new treatments due to strict eligibility rules. These new treatments, such as lecanemab and aducanumab, use monoclonal antibodies to tackle the amyloid-ß deposits in the brain. However, only a small number of early-stage patients qualify for these clinical trials.…
-
Alzheimer’s Breakthroughs Fuel Parkinson’s Research Revolution
Reading Time: 5 minutes. Groundbreaking progress in Alzheimer’s research is now leading to a renaissance in Parkinson’s disease studies. This report examines the far-reaching effects these strides have had on the Parkinson’s research sector. It looks into partnerships, clinical trials, funding, disease mechanisms, and improvements in trial design. Over the past decade, Alzheimer’s research has…
-
Did Methylene Blue Aid in the Battle Against Covid-19? A Summary
Reading Time: 8 minutes. As you navigate the ever-changing landscape of COVID-19 treatments and preventative measures, you may come across methylene blue, a substance with a history rich in medical applications. This article will explore whether methylene blue has played a role in the fight against COVID-19 by examining its properties, historical uses in combating…
-
Counselling Matters: Seeking Support for ADHD Challenges
Reading Time: 7 minutes. In the realm of mental health, individuals facing attention deficit hyperactivity disorder (ADHD) encounter a unique set of challenges that can significantly impact their daily functioning. To address these challenges and seek effective support, ADHD counselling emerges as a crucial intervention. This article aims to explore the importance of ADHD counselling,…
-
Methylene Blue as a Disinfectant: Investigating Its Antimicrobial Properties
Reading Time: 10 minutes. Imagine a world where germs rule supreme, and all our efforts to eradicate them are ineffective. Although it may sound like the plot of a dystopian novel, this could become a reality if we fail to find effective methods to combat these tiny threats. Fortunately, there is hope on the horizon…
Methylene Blue 1% Mind Booster
